| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 230,209 | 242,568 | 234,288 | 254,004 | | Cost of Revenue | 118,123 | 179,574 | 185,423 | (126,756) | | | Gross Profit | 112,086 | 62,994 | 48,865 | 380,760 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 74,282 | 13,668 | 6,818 | 329,643 | | Non Recurring | 2,080 |
-
| 1,368 | 70,069 | | Others | 37,982 | 36,657 | 37,385 | 36,759 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,258) | 12,669 | 3,294 | (55,711) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 723 | (594) |
-
|
-
| | Earnings Before Interest And Taxes | (65,888) | 11,945 | (130) | (64,491) | | Interest Expense | (44,074) | 22,782 | 21,292 | 23,903 | | Income Before Tax | (21,814) | (10,837) | (21,422) | (88,394) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 334 | 131 |
-
| 1,088 | | | | Net Income From Continuing Ops | (25,605) | (10,837) | (21,422) | (88,394) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (25,140) | (10,837) | (21,422) | (88,394) | | Preferred Stock And Other Adjustments | (9,678) | (10,036) | (9,320) | (9,679) | | | Net Income Applicable To Common Shares | ($34,818) | ($20,873) | ($30,742) | ($98,073) |
|
0.51% Nasdaq 
Income Statement
